Advertisement
Advertisement

UNITE to tackle dementia – $3 at a time

Dementia is the next big health and social crisis the world will have to face after COVID-19, according to the World Health Organisation (WHO), with numbers set to soar in the coming years. Predicted numbers...

Funding success for Otago in 2020 Health Research Council grants

Ten University of Otago proposals have been awarded funding through the Health Research Council’s (HRC) new Health Delivery Research Investment round. The 32 research grants are the first of two funding announcements for the...

New support service for Kiwis living with eating disorders

A new type of support to help New Zealanders healing from an eating disorder take positive steps towards full recovery has launched. Canopy Eating Disorders Support Services (Canopy) is New Zealand's first eating-disorder-specific peer-to-peer support,...

New Zealanders better off under marijuana legalisation: Government economic reports

Two reports by economic thinktank BERL analysing the current illicit marijuana market and how a new legal model would benefit New Zealand were released yesterday. The economic reports were commissioned by the Ministry of Justice...

PHARMAC seeking views on widened access to juvenile idiopathic arthritis medicines

PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to enable more young people with juvenile idiopathic arthritis to benefit from these medicines. Juvenile idiopathic arthritis (JIA) is an...

Kiwi kids to get helping hand with managing life’s challenges

A free programme aimed at equipping school children with tools to navigate life’s ups and downs will soon be available to any primary or intermediate school in New Zealand. Southern Cross, New Zealand’s leading independent...

PHARMAC seeking views on new type 2 diabetes medicines

PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2 diabetes. The medicines are empagliflozin (brand name Jardiance), empagliflozin with metformin (brand name Jardiamet),...

Cochlear implants: Are we meeting the standard of care in New Zealand?

https://www.youtube.com/watch?v=s5oaQv2ock8&t=7s Michel Neeff, ENT and Cochlear Implant Surgeon, questions why only 1 in 20 adults in New Zealand are getting access to life-changing cochlear implant technology. For over 30 years in New Zealand, cochlear implants have...

New partnership sets ‘gold standard’ for maternity care in NZ

A ceremonial handover of the Te Papaioea Birthing Centre in Palmerston North will cement a new partnership heralded as the “gold standard” of maternity and postnatal care for all New Zealand. MidCentral District Health Board assumed responsibility...

Kaiāwhina to guide the next 5-year Action Plan for the Kaiāwhina workforce

The first and formative 5-year Kaiāwhina Workforce Action Plan 2015-2020 concluded in June 2020, having helped to build an enduring foundation for the future of the Kaiāwhina workforce. The term ‘Kaiāwhina’ is a taonga (treasure)...
Advertisement

DR WELLNESS

Opinion: Hope is the key

In an example of conventional medicine at its worst, a patient of mine recently had her beautiful hope dashed. This inspiring young mum of two...

SPONSORED ARTICLES

Psychological support for the wellbeing of Frontline healthcare workers during the...

Sponsored article chnnl (pronounced channel), an app which anonymously tracks employee mental wellbeing, is helping healthcare providers across New Zealand provide psychological support for the...
X